Critical Limb Ischemia

Efficacy and Safety of Stempeucel® in Patients With Critical Limb Ischemia (CLI) Due to Peripheral Arterial Disease

Efficacy and Safety of Stempeucel® in Patients With Critical Limb Ischemia (CLI) Due to Buerger's Disease

Efficacy and Safety of Apixaban in Reducing Restenosis and Limb Loss in PAD Patients.

The DES BTK Vascular Stent System vs PTA in Subjects With Critical Limb Ischemia

Efficacy and Safety of AMG0001 in Subjects With Critical Limb Ischemia

An Efficacy and Safety Study of Ixmyelocel-T in Patients With Critical Limb Ischemia (CLI)

Study of Remodulin in Patients With Critical Limb Ischemia With No Planned Revascularization Procedures

Distal Venous Arterialisation of Ischemic Limb

Study to Assess the Efficacy and Safety of CLBS12 in Patients with Critical Limb Ischemia (CLI)

ACP-01 in Patients With Critical Limb Ischemia

A Phase IIB Pilot Study of a Modified Dosage Regimen of AMG0001 in Subjects With Critical Limb Ischemia

A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease

Intramuscular Mononuclear Cells and Mesenchymal Stem Cells Transplantation to Treat Chronic Critical Limb Ischemia

Application of Cell Regeneration Therapy With Mesenchymal Stem Cells From Adipose Tissue in Critical Chronic Ischemic Syndrome of Lower Limbs (CLI) in Nondiabetic Patients.

Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia

Safety Study of UT-15C SR (Oral Treprostinil) in Patients Undergoing a Lower Limb Endovascular Procedure

YQ23 Study in Patients With Critical Limb Ischaemia

Mesenchymal Stem Cells in Critical Limb Ischemia

Cell Therapy With Mesenchymal Stem Cell in Ischemic Limb Disease

Safety Study of Gene Therapy in Treating Critical Leg Ischemia

Drug Eluting Temporary Spur Stent System vs Percutaneous Balloon Angioplasty for the Treatment of Critical Limb Ischemia

Serrantor OCT Study

PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia

MOTIV BTK Randomized Controlled Trial

The Use of FlowMet-R Technology to Predict Wound Healing in CLI Patients in a Wound Care Center Setting

The CLI-AMP Registry

Natural Progression of High-Risk Chronic Limb-Threatening Ischemia: The CLariTI Study

SCOPE CLI (Shifting Care and Outcomes for Patients With Endangered Limbs - Critical Limb Ischemia)

Percutaneous Deep Vein Arterialization Post-Market Study

PROMISE II: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia

PROMISE International

Feasibility Clinical Trial Using the SPUR System to Demonstrate Safety and Efficacy.

PROMISE I Early Feasibility Trial of the LimFlow Stent Graft System

Stellarex DCB Versus Standard Balloon Angioplasty for Treatment of Below-The-Knee (BTK) Arteries

IN.PACT BTK Randomized Study to Assess Safety and Efficacy of IN.PACT 014 vs. PTA

A Long Term Follow-up Study of AMG0001 in Subjects With Critical Limb Ischemia

Evaluation of the Tissue Genesis® Icellator Cell Isolation System™ to Treat Critical Limb Ischemia

Best Endovascular vs. Best Surgical Therapy in Patients With Critical Limb Ischemia

Tack Optimized Balloon Angioplasty Below the Knee (TOBA - BTK) Study

External Compression Therapy for Secondary Prevention of Lower-Limb Loss and Cardiovascular Mortality

Cryopreserved Saphenous Vein Allograft in Patients With Critical Limb Ischemia for Peripheral Revascularization

Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)

Safety & Feasibility Study of Tack-It Device for Vessel Dissection Repair

Safety and Effect of Adipose Tissue Derived Mesenchymal Stem Cells Implantation in Patients With Critical Limb Ischemia

Validation of OxyVu for Assessing Level of Amputation With Comparison to Other Modalities